Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vildagliptin vs Dapagliflozin on Glucagon Response in T2D
NCT02475070Phase 4Completed
- Sponsor
- Lund University
- Start
- Jan 2016
- Primary completion
- Jun 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of vildagliptin, dapagliflozin in type 2 diabetes mellitus (T2DM), sponsored by Lund University. Started Jan 2016; status: completed.
02
Drugs
vildagliptindapagliflozin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02475070.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02475070.